A technetium-99m red cell survival technique for in vivo compatibility testing

Area of Science:

• Nuclear medicine
• Hematology
• Medical imaging

Background:

• Accurate red blood cell survival and compatibility assessment is crucial for safe blood transfusions.
• Traditional methods may have limitations in simultaneous or rapid testing.

Observation:

• A novel in vitro labeling technique for red blood cells using Technetium-99m (99mTc) and stannous pyrophosphate was developed.
• The 99mTc labeling allowed for simultaneous determination of autologous and heterologous red cell survival within 60 minutes.
• In vivo compatibility testing in a patient with panagglutinin showed identical results to Chromium-51 (51Cr) labeling.

Findings:

• The 99mTc labeling method demonstrated no significant elution over 1 hour in nine studies.
• Simultaneous testing of multiple donor units or serial testing over days was feasible.
• This technique offers a reliable alternative for red cell survival and compatibility studies.

Implications:

• The developed 99mTc labeling technique enhances the efficiency and accuracy of red blood cell survival and compatibility testing.
• This method can improve pretransfusion compatibility assessments, especially in complex cases like panagglutinin.
• It provides a valuable tool for both clinical diagnostics and research in transfusion medicine.